Leslie Global Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Buy
869
+11
+1% +$11.2K 0.41% 29
2026
Q1
$789K Sell
858
-4
-0.5% -$4.05K 0.42% 24
2025
Q4
$926K Buy
862
+10
+1% +$9.56K 0.42% 25
2025
Q3
$650K Sell
852
-8
-0.9% -$5.95K 0.3% 34
2025
Q2
$670K Buy
860
+509
+145% +$396K 0.36% 35
2025
Q1
$290K Sell
351
-44
-11% -$36.6K 0.14% 61
2024
Q4
$305K Sell
395
-5
-1% -$4.14K 0.14% 55
2024
Q3
$354K Buy
+400
New +$360K 0.17% 52

Other funds holding LLY

Leslie Global Wealth's LLY Position: Q2 2026 in Review

Leslie Global Wealth increased its Eli Lilly (LLY) stake by 1.3% in Q2 2026, buying an estimated $11.2K and bringing the position to 869 shares worth $1.04M. The position accounts for 0.41% of the portfolio, ranked #29.

Leslie Global Wealth first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Leslie Global Wealth held 869 shares of Eli Lilly worth $1.04M as of Q2 2026.
  • Leslie Global Wealth bought 11 Eli Lilly shares in Q2 2026, an estimated $11.2K.
  • Eli Lilly made up 0.41% of Leslie Global Wealth's portfolio in Q2 2026, its #29 holding.
  • Leslie Global Wealth first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Leslie Global Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.